UroGen Pharma Ltd. (URGN)
NASDAQ·Healthcare·Biotechnology
$32.78
+2.58%
Mkt Cap $1.45B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (11 analysts)
$40.00
Range $40.00 – $40.00
Implied Upside
+22.0%
Consensus $40.00 vs current $32.78
NASDAQ·Healthcare·Biotechnology
$32.78
+2.58%
Mkt Cap $1.45B
Buy
8
Hold
0
Sell
0
Price Target (11 analysts)
$40.00
Range $40.00 – $40.00
+22.0%
Consensus $40.00 vs current $32.78